Codman & Shurtleff, a Johnson & Johnson company, will have its surgical instrumentation line integrated with Symmetry’s current hospital direct business. The business line will be named Symmetry Surgical and is expected to produce more than $100 million in annual sales.
Related Articles on Orthopedic Devices:
Orthopedic Researchers Discover New Factor in Metal on Metal Hip Implant Design
RoG Sports Medicine Receives FDA Clearance for Suture Anchor
International Consortium of Orthopaedic Registries Reports on Progress
Symmetry Medical Completes Acquisition of Surgical Implants Company
Symmetry Medical, a Warsaw, Ind.-based orthopedic device company, recently closed on its acquisition of the surgical implants business Codman & Shurtleff, according to a Symmetry news release.
From fragmented fixes to systemwide control: UVA Health’s approach to drug shortage management and supply chain transformation
Recommended Live Webinar on Jan 27, 2026 11:00 AM - 12:00 PM CST